Serge Saxonov is Chief Executive Officer of 10x Genomics, Inc.. Currently has a direct ownership of 884,574 shares of TXG, which is worth approximately $13.8 Million. The most recent transaction as insider was on Jan 04, 2021, when has been sold 10,000 shares (Class A Common Stock) at a price of $140.43 per share, resulting in proceeds of $1,404,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 885K
0.24% 3M change
2.81% 12M change
Total Value Held $13.8 Million

Serge Saxonov Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 04 2021
SELL
Open market or private sale
$1,404,300 $140.43 p/Share
10,000 Reduced 1.12%
880,468 Class A Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$50,400 $5.04 p/Share
10,000 Added 1.11%
890,468 Class A Common Stock
Dec 22 2020
BUY
Exercise of conversion of derivative security
$4,137 $1.14 p/Share
3,629 Added 0.41%
880,468 Class A Common Stock
Dec 14 2020
BUY
Bona fide gift
-
15,000 Added 1.68%
876,839 Class A Common Stock
Dec 10 2020
SELL
Bona fide gift
-
104,960 Reduced 10.86%
861,839 Class A Common Stock
Dec 08 2020
SELL
Bona fide gift
-
382 Reduced 0.04%
966,799 Class A Common Stock
Dec 01 2020
SELL
Open market or private sale
$1,520,100 $152.01 p/Share
10,000 Reduced 1.02%
967,181 Class A Common Stock
Dec 01 2020
BUY
Exercise of conversion of derivative security
$31,200 $3.12 p/Share
10,000 Added 1.01%
977,181 Class A Common Stock
Nov 03 2020
SELL
Open market or private sale
$400,617 $137.01 p/Share
2,924 Reduced 0.3%
967,181 Class A Common Stock
Nov 03 2020
BUY
Exercise of conversion of derivative security
$14,737 $5.04 p/Share
2,924 Added 0.3%
970,105 Class A Common Stock
Nov 02 2020
SELL
Open market or private sale
$968,068 $136.81 p/Share
7,076 Reduced 0.73%
967,181 Class A Common Stock
Nov 02 2020
BUY
Exercise of conversion of derivative security
$22,077 $3.12 p/Share
7,076 Added 0.72%
974,257 Class A Common Stock
Oct 01 2020
SELL
Open market or private sale
$1,253,200 $125.32 p/Share
10,000 Reduced 1.02%
967,181 Class A Common Stock
Oct 01 2020
BUY
Exercise of conversion of derivative security
$31,200 $3.12 p/Share
10,000 Added 1.01%
977,181 Class A Common Stock
SS

Serge Saxonov

Chief Executive Officer
Pleasanton, CA

Track Institutional and Insider Activities on TXG

Follow 10x Genomics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG